Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia? [electronic resource]
Producer: 20190729ISSN:- 1757-790X
- Adult
- Antipsychotic Agents -- adverse effects
- Clopenthixol -- therapeutic use
- Dopamine Antagonists -- therapeutic use
- Drug Therapy, Combination
- Hallucinations -- drug therapy
- Humans
- Male
- Olanzapine -- therapeutic use
- Paranoid Disorders -- chemically induced
- Receptors, Dopamine -- drug effects
- Schizophrenia -- complications
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.